COVID-19 vaccine patents: to waive or not to waive?

Nari Lee, Gyöngyi Kovacs

Research output: Contribution to journal › Article › Professional

Original language	English
Trade journal	IPR-Info
Volume	2021
Issue number	3
ISSN	1799-909X
Publication status	Published - 10.05.2021
MoE publication type	D1 Article in a trade journal

Keywords

513 Law
patentit

Areas of Strength and Areas of High Potential (AoS and AoHP)

AoHP: Digitisation and sustainability in intellectual property
AoHP: Humanitarian and societal logistics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://iprinfo.fi/artikkeli/covid-19-vaccine-patents-to-waive-or-not-to-waive/

OpenUrl availability

HEROS: Health Emergency Response in Interconnected Systems
Kovacs, G., Falagara Sigala, I., Hamid Abakar, A. & Sarker, S.
01.04.2020 → 31.05.2023
Project: Externally funded project
FAirness, Morality and Equality in international and European Intellectual Property Law (FAME-IP)
Lee, N., Jongsma, D., Bruun, N., Cadillo Chandler, D., Antikainen, M., Kallio, S., Kur, A., Sandeen, S., Simon, D. & Calboli, I.
Academy of Finland
01.07.2018 → 31.12.2022
Project: Externally funded project

Cite this

@article{4157339269e048a19ca1e32b606cb285,

title = "COVID-19 vaccine patents: to waive or not to waive?",

keywords = "513 Law, patentit",

author = "Nari Lee and Gy{\"o}ngyi Kovacs",

year = "2021",

month = may,

day = "10",

language = "English",

volume = "2021",

journal = "IPR-Info",

issn = "1456-9914",

publisher = "IPR University Center Association",

number = "3",

}